Pang, Shuguang
108  Ergebnisse:
Personensuche X
?
3

Circulating asprosin concentrations in individuals with new..:

Diao, Hongcui ; Fan, Xiujie ; Li, Zhe...
Diabetes Research and Clinical Practice.  213 (2024)  - p. 111730 , 2024
 
?
4

Pharmacokinetics, Pharmacodynamics and Safety of Janagliflo..:

Zhao, Hengli ; Zhao, Zhirui ; He, Kun...
Clinical Pharmacokinetics.  62 (2023)  8 - p. 1093-1103 , 2023
 
?
6

Risk Factors for Diabetic Retinopathy in Chinese Patients w..:

Li, Jianting ; Dong, Zhenhua ; Wang, Xiaoli...
International Journal of General Medicine.  16 (2023)  - p. 4027-4037 , 2023
 
?
7

Asprosin, a novel glucogenic adipokine implicated in type 2..:

Diao, Hongcui ; Li, Xue ; Xu, Yeqiu..
Journal of Diabetes and its Complications.  37 (2023)  11 - p. 108614 , 2023
 
?
8

Efficacy and safety of janagliflozin monotherapy in Chinese..:

Ji, Linong ; Jiang, Xiaozhen ; Hao, Qingshun...
Diabetes, Obesity and Metabolism.  25 (2023)  5 - p. 1229-1240 , 2023
 
?
9

Efficacy and safety of janagliflozin as add‐on therapy to m..:

Gao, Leili ; Cheng, Zhifeng ; Su, Benli...
Diabetes, Obesity and Metabolism.  25 (2022)  3 - p. 785-795 , 2022
 
?
 
1-15